Private limited company · Lillehammer
AQUA PHARMA GROUP AS
ActiveBusiness and other management consultancy activities (70.200)
The life line 2019–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 169.3m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
AQUA PHARMA GROUP AS is a private limited company in Lillehammer, founded in 2019, in the industry business and other management consultancy activities. The chief executive is Elvin Ronald Bugge, and the chair of the board is Marco Giannuzzi. In 2025 the company had NOK 169.3m in operating revenue and a net profit of NOK 80.1m; the group had revenue of NOK 533.5m. The largest owner is AQUATIQ GROUP AS with 50.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 1 Sep 2026
- Annual accounts filed 2024 → 2025
- Godkjent årsregnskap
- Endring av revisor
- Endring av styre
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
3 points
- NoteChanged auditor 14 Feb 2026
- Note2 of 4 on the board are new in the last 12 months
- OKEquity ratio 77.8%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 169.3m in 2025
Revenue
NOK 169.3m
+6.2% from 2024
20232025
Operating profit
NOK 101.5m
−2.7% from 2024
20232025
Net profit
NOK 80.1m
+127.8% from 2024
20232025
Equity
NOK 314.5m
+18.9% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2024
Of every krone of operating revenue in 2024:
- Wages and social costs 6%
- Depreciation 0%
- Other operating costs 25%
- Not specified in the source 4%
- Left as operating result 65%
Of the net profit for 2024, NOK 5.1m stayed in the company. The rest, NOK 30.0m, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 77.8%
- AQUA PHARMA GROUP AS, 2025
- Industry median, assumed: NOK 654k · 7.5% · 54.4% · +0.9%
Equity NOK 314.5m78% of the assets (NOK 404.2m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 9,753 companies in 70.200 Business and other management consultancy activities, not stated by the source.
Finances
§ 06 Accounts
7 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 169,262 | 159,362 | 42,621 | |
| Operating profit | 101,522 | 104,369 | −7,174 | |
| Profit before tax | 100,850 | 56,305 | −48,683 | |
| Net profit | 80,062 | 35,140 | −48,683 | |
| Total assets | 404,221 | 341,406 | 307,188 | |
| Equity | 314,452 | 264,391 | 259,251 | |
| Liabilities | 89,768 | 77,015 | 47,937 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 7 years →
Management and ownership
§ 07 Officers
6 officers now
- Elvin Ronald BuggeChief executive since 2020
- Marco GiannuzziChair of the board since 2024
- TELL NORGE ASAuditor since 2026
- Ines Hurtado DominguezBoard member since 2026
- Heidi Camilla Sagen-OhrenBoard member since 2026
- Eirik BuggeBoard member since 2024
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 6 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
To styremedlemmer i fellesskap.
May sign for the company:
To styremedlemmer i fellesskap.
Procuration: none registered.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 3 Oct 2026
Management and ownership
§ 09 Owners
1 shareholder · largest 50.0%
| Owner | Share |
|---|---|
| AQUATIQ GROUP AS | 50.0% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →
Management and ownership
§ 10 Group
3 subsidiaries
The group 2025: operating revenue NOK 533.5m (+8.1%).
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
17 connections
- Person
- Company
3 people link AQUA PHARMA GROUP AS to 9 other companies: Elvin Ronald Bugge 5, Eirik Bugge 5 and Heidi Camilla Sagen-Ohren 4.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
22 since 2019
Events per year
20192026
Since 2019: 21 announcements and 1 register change. Most happened in 2019 and 2020.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 22 events →
Events and registers
§ 14 Notices
21, latest 31 Aug 2026
- Godkjente årsregnskap
- Revisor
- Styre
Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 21 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 23 Apr 2019
- VATRegistered
- The Register of Business EnterprisesRegistered 23 Apr 2019
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Salg og utvikling av produkter for parasittbehandling innen akvakultur samt investering og eierskap i selskaper med tilsvarende virksomhet.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 70.200
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
7 questions
- Who is the chief executive of AQUA PHARMA GROUP AS?
Elvin Ronald Bugge, since 2020. § 07 - Who owns AQUA PHARMA GROUP AS?
1 shareholder. It is AQUATIQ GROUP AS with 50.0%. § 09 - What was the revenue in 2025?
NOK 169.3m in the company and NOK 533.5m in the group. § 06 - Who can sign for AQUA PHARMA GROUP AS?
To styremedlemmer i fellesskap. § 08 - Who is the auditor?
TELL NORGE AS, from 14 Feb 2026. § 07 - Where is AQUA PHARMA GROUP AS based?
Hovemovegen 1, 2624 Lillehammer. - When was AQUA PHARMA GROUP AS founded?
29 Mar 2019, registered in the Register of Business Enterprises 23 Apr 2019. § 16
The answers come from the sections linked to, with their sources.